News
KNBIF
0.090
NaN%
--
Weekly Report: what happened at KNBIF last week (0422-0426)?
Weekly Report · 4d ago
Weekly Report: what happened at KNBIF last week (0415-0419)?
Weekly Report · 04/22 12:28
Kane Biotech to Host Investor Webinar
Barchart · 04/16 08:15
KANE BIOTECH ANNOUNCES CLOSING OF THE SALE OF STEM ANIMAL HEALTH TO DECHRA VETERINARY PRODUCTS
Reuters · 04/15 13:15
Weekly Report: what happened at KNBIF last week (0408-0412)?
Weekly Report · 04/15 12:18
KANE BIOTECH INC: ANTICIPATES USING NET PROCEEDS FROM TRANSACTION TO REPAY ITS OUTSTANDING LOAN TO PIVOT FINANCIAL I LIMITED PARTNERSHIP
Reuters · 04/11 13:45
Kane Biotech Announces Agreement in Principle for the Sale of its Interest in STEM Animal Health
Kane Biotech Inc. Has reached an agreement in principle for the sale of its entire interest in STEM Animal Health Inc. To a third party pharmaceutical company for US $8,000,000. The sale is expected to net Kane Biotech in excess of $11,500,000 .
Barchart · 04/11 08:45
Weekly Report: what happened at KNBIF last week (0401-0405)?
Weekly Report · 04/08 12:23
Weekly Report: what happened at KNBIF last week (0325-0329)?
Weekly Report · 04/01 12:20
Kane Biotech GAAP EPS of -$0.01
Kane Biotech Inc. Reports Q4 GAAP EPS of -$0.01. Total revenue for the three months ended December 31, 2023 was $764,997, an increase of 11% over the same period in 2022. Kane Biotech's stock is trading at $0.02.
Seeking Alpha · 03/26 20:46
Weekly Report: what happened at KNBIF last week (0318-0322)?
Weekly Report · 03/25 12:23
Kane Biotech to Release Fourth Quarter and Full Year 2023 Financial Results on March 26, 2024 – Conference Call to Follow
Kane Biotech Inc. Will announce its fourth quarter and full year 2023 financial results after market close on March 26, 2024. Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies that prevent and remove microbial biofilms.
Barchart · 03/19 15:10
Weekly Report: what happened at KNBIF last week (0311-0315)?
Weekly Report · 03/18 12:21
Weekly Report: what happened at KNBIF last week (0304-0308)?
Weekly Report · 03/11 12:16
Kane Biotech Receives Bioscience Association Manitoba Company of the Year Award
Kane Biotech Inc. Received the BAM Company of the Year award at the Bioscience Association of Manitoba's annual awards dinner held on March 7, 2024. Kane Biotech received the award for the best company of the year in Manitoba. The company is a biotechnology company.
Barchart · 03/08 08:00
Weekly Report: what happened at KNBIF last week (0226-0301)?
Weekly Report · 03/04 12:21
Weekly Report: what happened at KNBIF last week (0219-0223)?
Weekly Report · 02/26 12:41
Weekly Report: what happened at KNBIF last week (0212-0216)?
Weekly Report · 02/19 12:43
Weekly Report: what happened at KNBIF last week (0205-0209)?
Weekly Report · 02/12 12:27
Weekly Report: what happened at KNBIF last week (0129-0202)?
Weekly Report · 02/05 12:41
More
Webull provides a variety of real-time KNBIF stock news. You can receive the latest news about Kane Biotech Inc through multiple platforms. This information may help you make smarter investment decisions.
About KNBIF
Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the development and commercialization of products that prevent and remove microbial biofilms. The Company's technologies include DispersinB, AloSera, Aledex, Strix NB, bluestem and KBI Disinfectant. It is focused on the companion animal market with Strix NB brand for the veterinary segment and bluestem brand for the pet over the counter (OTC) retail market. The Company markets its oral care technology into the Canadian pet specialty market under the bluestem brand. It has over 100 pet specialty stores in Canada, which are engaged in selling the bluestem oral health products. It has various formulations in development, including formulations with antibiotics and the antibiofilm enzyme beta-N-Acetylglucosaminidase and antibiofilm-antimicrobial formulations for both the veterinary and human markets. It is focused on the development of oral care spray formulation and a water additive powder formulation.